|
[1]
|
Pearce, F., Craven, A., Merkel, P., et al. (2017) Global Ethnic and Geographic Differences in the Clinical Presentations of Anti-Neutrophil Cytoplasm Antibody-Associated Vasculitis. Rheumatology, 56, 1962-1969. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Li, J., Cui, Z., Long, J.Y., et al. (2018) The Frequency of ANCA-Associated Vasculitis in a National Database of Hospitalized Patients in China. Arthritis Research & Therapy, 20, 226. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
张立民, 吴庆军, 冯胜, 等. 5种ANCA相关性血管炎活动性评分量表的比较[J]. 首都医科大学学报, 2010, 31(1): 103-105.
|
|
[4]
|
Tedesco, M., Gallieni, M., Pellegata, F., et al. (2019) Update on ANCA-Associated Vasculitis: From Biomarkers to Therapy. Journal of Nephrology, 32, 871-882. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Hinojosa-Azaola, A. and Jiménez-González, A. (2017) Histopathologic Classification of Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis: Achievements, Limitations, and Perspectives. Clinical Rheumatology, 36, 1949-1957. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Chen, M., Yu, F., Zhang, Y., et al. (2005) Clinical and Patholog-ical Characteristics of Chinese Patients with Antineutrophil Cytoplasmic Autoantibody Associated Systemic Vasculitides: A Study of 426 Patients from a Single Centre. Postgraduate Medical Journal, 81, 723-727. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Wu, T., Zhong, Y., Zhou, Y., et al. (2020) Clinical Characteristics and Prognosis in 269 Patients with Antineutrophil Cytoplasimc Antibody Associated Vasculitis. Journal of Central South University. Medical Sciences, 45, 916-922.
|
|
[8]
|
Shuai, Z.W., Lv, Y.F., Zhang, M.M., et al. (2015) Clinical Anal-ysis of Patients with Myeloperoxidase Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Genetics and Molec-ular Research, 14, 5296-5303. [Google Scholar] [CrossRef]
|
|
[9]
|
Homma, S., Suzuki, A. and Sato, K. (2013) Pulmonary Involvement in ANCA-Associated Vasculitis from the View of the Pulmonologist. Clinical and Experimental Nephrology, 17, 667-671. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Hasegawa, M., Hattori, K., Sugiyama, S., et al. (2016) A Retrospective Study on the Outcomes of MPO-ANCA-Associated Vasculitis in Dialysis-Dependent Patients. Modern Rheumatology, 26, 110-114. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Walton, E. (1958) Giant-Cell Granuloma of the Respiratory Tract (Wegener’s Granulomatosis). British Medical Journal, 2, 265-270. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Semple, J., Italiano, J. and Freedman, J. (2011) Platelets and the Im-mune Continuum. Nature Reviews Immunology, 11, 264-274. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Willeke, P., Kumpers, P., Schluter, B., et al. (2015) Platelet Counts as a Biomarker in ANCA-Associated Vasculitis. Scandinavian Journal of Rheumatology, 44, 302-308. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Fauci, A.S., Haynes, B.F., Katz, P., et al. (1983) Wegener’s Granulomatosis: Prospective Clinical and Therapeutic Experience with 85 Patients for 21 Years. Annals of Internal Medicine, 98, 76-85. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Hoffman, G.S., Kerr, G.S., Leavitt, R.Y., et al. (1992) Wegener Granulomatosis: An Analysis of 158 Patients. Annals of Internal Medicine, 116, 488-498. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Huang, L., Zhong, Y., Ooi, J.D., et al. (2019) The Effect of Pulse Methylprednisolone Induction Therapy in Chinese Patients with Dialysis-Dependent MPO-ANCA Associated Vasculitis. International Immunopharmacology, 76, Article ID: 105883. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Yang, L., Xie, H., Liu, Z., et al. (2018) Risk Factors for Infec-tious Complications of ANCA-Associated Vasculitis: A Cohort Study. BMC Nephrology, 19, Article No. 138. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Kronbichler, A., Kerschbaum, J., Gopaluni, S., et al. (2018) Tri-methoprim-Sulfamethoxazole Prophylaxis Prevents Severe/Life-Threatening Infections Following Rituximab in Antineu-trophil Cytoplasm Antibody-Associated Vasculitis. Annals of the Rheumatic Diseases, 77, 1440-1447. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Casal Moura M, Irazabal M, Eirin A, et al. (2020) Effica-cy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Renal Disease. Journal of the American Society of Nephrology: JASN, 31, 2688-2704. [Google Scholar] [CrossRef]
|
|
[20]
|
Novikov, P., Bulanov, N., Zykova, A., et al. (2020) Prevention of Infections in Patients with Antineutrophil Cytoplasm Antibody-Associated Vasculitis: Potential Role of Hydroxychloro-quine. Annals of the Rheumatic Diseases, 79, e19. [Google Scholar] [CrossRef] [PubMed]
|